2022
DOI: 10.3389/fonc.2022.912101
|View full text |Cite
|
Sign up to set email alerts
|

Increased ASF1B Expression Correlates With Poor Prognosis in Patients With Gliomas

Abstract: BackgroundSeveral studies have suggested that anti-silencing function 1 B (ASF1B) can serve as a good potential marker for predicting tumor prognosis. But the values of ASF1B in gliomas have not been elucidated and further confirmation is needed.MethodsTranscriptomic and clinical data were downloaded from The Cancer Genome Atlas database (TCGA), genotypic tissue expression (GTEx), and the Chinese Gliomas Genome Atlas database (CGGA). Univariate and multivariate Cox regression analyses were used to investigate … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
0
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 42 publications
0
0
0
Order By: Relevance
“…Moreover, ASF1A and ASF1B interact with other histone chaperone proteins, fostering the chromatin regulation processes [ 38 ]. Over-expression or depletion of the ASF1A and ASF1B proteins is reported to be associated with carcinogenesis and tumorigenesis through interaction with other histone chaperone proteins [ 39 , 40 ].…”
Section: Resultsmentioning
confidence: 99%
“…Moreover, ASF1A and ASF1B interact with other histone chaperone proteins, fostering the chromatin regulation processes [ 38 ]. Over-expression or depletion of the ASF1A and ASF1B proteins is reported to be associated with carcinogenesis and tumorigenesis through interaction with other histone chaperone proteins [ 39 , 40 ].…”
Section: Resultsmentioning
confidence: 99%